Cargando…

Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC)

BACKGROUND: Our previous study examined an effect of remote ischemic preconditioning (RIPC) or intravenous nicorandil on reduction of periprocedural myocardial injury (pMI) following percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD). We further investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakita, Norifumi, Ejiri, Kentaro, Miyoshi, Toru, Kohno, Kunihisa, Nakahama, Makoto, Doi, Masayuki, Munemasa, Mitsuru, Murakami, Masaaki, Nakamura, Kazufumi, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901776/ https://www.ncbi.nlm.nih.gov/pubmed/29659585 http://dx.doi.org/10.1371/journal.pone.0194623

Ejemplares similares

Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2018)

Desde un rinc©đn neutral : Tango
por: Peyrano, Alberto
Publicado: (1986)

The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

The number of circulating CD34-positive cells is an independent predictor of coronary artery calcification progression: Sub-analysis of a prospective multicenter study
por: Ichikawa, Keishi, et al.
Publicado: (2022)

Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019)

Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention
por: Hu, Keqing, et al.
Publicado: (2020)

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017)

Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Xu, Xingli, et al.
Publicado: (2020)

Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease
por: Zong, Yulong, et al.
Publicado: (2021)

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
por: Yang, Jing, et al.
Publicado: (2015)

The Role of Nicorandil in the Management of Chronic Coronary Syndromes in the Gulf Region
por: Cheng, Kevin, et al.
Publicado: (2020)

Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention
por: Takagi, Wataru, et al.
Publicado: (2017)

Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention
por: Wang, Weiding, et al.
Publicado: (2019)

Intracoronary nicorandil induced hyperemia for physiological assessments in the coronary artery lesions
por: Yang, Xia, et al.
Publicado: (2022)

Intracoronary administration of nicorandil during primary percutaneous coronary intervention: Impact on restoration of regional myocardial perfusion in reperfused myocardium during the subacute phase of myocardial infarction
por: Takabatake, Wataru, et al.
Publicado: (2015)

Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
por: Ilyas, Maria, et al.
Publicado: (2023)

Radiation-Induced Short Channel (RISCE) and Narrow Channel (RINCE) Effects in 65 and 130 nm MOSFETs
por: Faccio, F, et al.
Publicado: (2015)

Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA Trial
por: Kohsaka, Shun, et al.
Publicado: (2023)

Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction
por: Feng, Chunguang, et al.
Publicado: (2018)

Intracoronary administration of nicorandil-induced cardiac arrest during primary percutaneous coronary intervention: A case report
por: Wei, Shu-Jian, et al.
Publicado: (2019)

Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study
por: Ichikawa, Keishi, et al.
Publicado: (2021)

Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men
por: Doi, Masayuki, et al.
Publicado: (2011)

Nicorandil Improves Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion
por: Chen, Shaomin, et al.
Publicado: (2022)

Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents
por: Kubo, Motoki, et al.
Publicado: (2015)

Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Wu, Muli, et al.
Publicado: (2013)

Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials
por: Wang, Xiaobing, et al.
Publicado: (2018)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
por: Ye, Ziliang, et al.
Publicado: (2018)

Nicorandil pretreatment inhibits myocardial apoptosis and improves cardiac function after coronary microembolization in rats
por: He, Wen-Kai, et al.
Publicado: (2018)

Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention
por: Sato, Shuji, et al.
Publicado: (2020)

Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
por: Wang, Shanjie, et al.
Publicado: (2019)

Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Jin, et al.
Publicado: (2020)

Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow
por: Chen, Zuoyuan, et al.
Publicado: (2015)

Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome
por: Du, Xiaozhi, et al.
Publicado: (2021)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
por: Campo, Gianluca, et al.
Publicado: (2017)

Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients
por: Yi, Bin, et al.
Publicado: (2020)

Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Li, Weijun, et al.
Publicado: (2021)

Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Himanshu, et al.
Publicado: (2022)

Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease
por: Wester, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n0s80984t5i9h22q8hgu09stsu